Best ASX dividend stocks for July 2026
Reading time: 7 minutes
Despite growth stocks occupying much of the glare of the spotlight, companies that reward shareholders with dividends have continued to play an important role in many long-term portfolios. Markets may remain volatile, but quality dividend stocks often continue to attract investors seeking a combination of income and the potential for capital appreciation.
In this article, we round up the best Australian Securities Exchange (ASX) dividend stocks worth watching this July. For each company, we review its recent performance, dividend history, and other key factors that may be relevant to investors.
Dusk Group Ltd
Dusk Group is a premier Australian specialty retailer of home fragrances - from candles and essential oils to diffusers and home decor. Its products are available in-store and online across New Zealand and Australia. Dusk reported AUD 126.7 million in net revenue and a net profit of AUD 4.3 million in FY2024. It has an appealing dividend yield of approximately 12.6%, which could attract income-focused traders. All thanks to Vladislav Yakubson, who was appointed CEO in late 2023, Dusk remains a force to be reckoned with for product excellence, innovation, and customer-centricity, cementing its position in the market as one of the leading players for home fragrance and gifting.
BHP Group Ltd
As one of the largest miners globally, BHP’s mandate is to discover, acquire, and market various natural commodities. Its operations mainly involve extracting copper, iron ore, and metallurgical coal, all of which are materials for large infrastructure development projects. In the past 6 months, BHP has turned its focus into expanding copper projects, a move that positions itself ready to jump into sustainable electrification trends.
BHP has a history of robust dividend generation, which makes it attractive for investors seeking large-cap stability. It also frequently generates free cash flow when prices of hard commodities strengthen. This cash generation allows BHP to pay fully franked dividends to its shareholders.
Aurizon Holdings Ltd
In FY2024, Aurizon reported revenues of AUD 3.84 billion and a net income of AUD 406 million. It is Australia’s largest rail freight operator, carrying over 250 million tonnes of freight annually and operating via three main lines of business: Network, Coal, and Bulk. Under a 99-year lease, Aurizon oversees the Central Queensland Coal Network, a 2,670-kilometer railway system that connects coal mines to export terminals. In and out of Queensland and New South Wales mines, Aurizon provides freight forwarding services for metallurgical and thermal coal from export terminals and to local customers. Lastly, it offers end-to-end supply chain solutions, including rail and road transport services as well as logistics services for various commodities like agricultural products, industrial goods, and minerals.
WAM Capital Ltd
Managed by Wilson Asset Management, WAM Capital Ltd is an Australian listed investment company whose main business is investing in undervalued growth companies like SMEs that are listed on the ASX. It seeks to provide shareholders with a stream of fully franked dividends, capital growth, and capital preservation.
As of June 2025, the company reported a net profit of AUD 229 million and has also offered a dividend yield of around 10%, although dividend yields can fluctuate over time.
Medibank Private Ltd
In the Australian health insurance market, Medibank Private Ltd is one of the largest providers. Under its Medibank and Australian Health Management (AHM) brands, the company serves millions of customers by providing comprehensive private health coverage for their needs. Over the years, Medibank has reported strong customer growth, aided by the growing public support for flexible health packages such as virtual care models, short-stay hospitals, and digital well-being initiatives. All these strategies may alleviate the pressure placed on public health institutions.
As healthcare insurance seems to have become essential for many families, Medibank's earnings remain steady and resilient despite economic downturns. This stability has supported dividend payments, which makes it a potential choice for maintaining cash flow within a trader’s portfolio.
Challenger Limited
Challenger is known as one of Australia’s largest providers of annuities and retirement income products. It specialises in converting savings of retirees into guaranteed and predictable income streams. Having partnered with international insurance giants like Dai-Ichi Life, Challenger operates through two segments: (1) a Life Division that creates structured financial products, and (2) a Funds Management business that manages a wide range of global assets.
Challenger is well positioned to capture a structural macroeconomic tailwind; that is Australia’s aging population and a substantial amount of wealth passing through retirement phases. This stock remains popular with investors as higher interest rates tend to increase demand for its core annuity products, which supports healthier profit margins and potential dividends. However, future dividend payments remain subject to the company's earnings, financial position, and board approval.
AFT Pharmaceuticals Ltd
AFT Pharmaceuticals develops, licenses, and distributes a broad range of health products around the world. Recently, it expanded its distribution of pain relief products to pharmacies in the UK and Canada. It has a reported market cap of AUD 327.53 million and a dividend yield of 0.67%.
AFT Pharmaceuticals could be well suited for share traders seeking defensive healthcare exposure as well as room for global growth. Its royalty and licensing income has grown as more of its products are launched across international markets.
As always, we recommend that traders conduct their own research and learn more about the companies they will invest in, before purchasing ASX-listed shares.
Trade CFDs on ASX dividend stocks with FP Markets
If you’re looking to take advantage of income-yielding shares from Australia’s top dividend-paying companies, FP Markets can be your partner in helping you access a broad range of ASX-listed share contracts for difference (CFDs). Instead of purchasing the underlying shares outright, you can trade CFDs and speculate on whether the share price of the companies above will rise or fall.
FP Markets offers access to more than 10,000 share CFDs across Australian and global markets through leading broker platforms such as MetaTrader 4 and 5, TradingView, cTrader and many more!
Frequently asked questions (FAQs)
Dividend stocks are shares in companies that distribute a portion of their profits to shareholders in the form of dividends. Many investors include dividend-paying stocks in their portfolios to generate regular income while also aiming to benefit from potential long-term capital growth.
Not necessarily. A high dividend yield can be attractive, but it should be assessed alongside the company's financial health, earnings stability, payout ratio, and future growth prospects. Sustainable dividends are generally more valuable than unusually high yields that may not be maintained.
Yes. With share CFDs, traders can speculate on the price movements of ASX-listed companies without purchasing the underlying shares. CFD trading also allows traders to take positions in both rising and falling markets, although they do not receive the ownership rights associated with holding physical shares.
